In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Epigenomics Inc.

Division of Epigenomics AG

Latest From Epigenomics Inc.

Check-Cap Ltd.

Israel’s Check-Cap Ltd. is looking to increase compliance with colorectal cancer screening recommendations with its ingestible, X-ray-based, gastrointestinal imaging device. The Check-Cap Imaging Capsule is designed to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy, without a hospital visit or aggressive bowel preparation.

Medical Device

Regulatory Briefs: FDA Meetings On Cancer Tests, Glaucoma Devices; DeLauro Questions Device Reclassifications

An FDA advisory panel will discuss PMAs for two molecular diagnostics for colorectal cancer screening in March. A February workshop will address clinical trial design for minimally invasive glaucoma devices. Rep. DeLauro speaks out about FDA device reclassifications. More regulatory briefs.

Medical Device Regulation

Companion Dx Partnerships, M&A Deals Help Spur IVD Market Growth – PWC Report

A report from PricewaterhouseCoopers suggests the in vitro diagnostics market will see accelerated growth next year due in part to a surge in companion diagnostics partnerships and M&A deals.

Medical Device

In Vitro Diagnostics: The Quest For Growth

This article first appeared in Medtech Insight, October 2010.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Epigenomics AG
  • Senior Management
  • Noel Doheny, CEO
    Gary Schweikhardt, Pres. & COO
  • Contact Info
  • Epigenomics Inc.
    Phone: (206) 883-2900
    1000 Seneca Street
    Ste. 300
    P.O. Box 15259 Seattle, WA 98101